Research progress of adjuvant endocrine therapy for perimenopausal hormone receptor-positive breast cancer
LUAN Bi-qing
GE Fei
Abstract：Adjuvant endocrine therapy(AET)is an effective treatment strategy for patients with hormone receptor-positive breast cancer and can make the patients obtain significant survival benefits and reduce the risk of recurrence.To determine the most appropriate treatment strategy,AET for early breast cancer should consider a patient's risk of disease recurrence and menopausal status at the time of diagnosis.The population in perimenopause is the population with high incidence of breast cancer.This paper focuses on the relevant research progress of AET for perimenopausal hormone receptor-positive breast cancer patients.
Keywords：Breast cancerPerimenopauseAdjuvant endocrine therapy(AET)
Publication Date：2023-12-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 1303-1307 )